3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Gastrointestinal
1
Conditions
Multiple Myeloma
8
Pancreatic Neoplasms
7
Neoplasms
6
Neoplasms, Plasma Cell
4
Myelodysplastic Syndromes
4
Colorectal Neoplasms
3
Stomatitis
2
Skin Neoplasms
2
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Myeloproliferative Disorders
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Inflammation
2
Colonic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Sarcoma
1
Recurrence
1
Primary Myelofibrosis
1
Myofibroma
1
Myelodysplastic-Myeloproliferative Diseases
1
Multiple Endocrine Neoplasia Type 1
1
Mucositis
1
Motor Activity
1
Lymphoma
1
Lung Neoplasms
1
Liver Neoplasms
1
Limb-girdle muscular dystrophy, type 2C
1
Interventions
beta Carotene
1
Vitamin E
1
Surgical Procedures, Operative
1
Immune Checkpoint Inhibitors
1
Geritol
1
Biopsy
1
Ascorbic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Eye Diseases
×
Ascorbic Acid
×
Clear all
NCT00270647
2018-02-28
PHS II
Brigham and Women's Hospital
Phase NA
Completed
14,641 enrolled